Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
319.9 INR | -0.12% | +7.84% | +1.39% |
Apr. 04 | Gufic Biosciences Forms New Wholly-Owned Arm in Dubai | MT |
Apr. 03 | Gufic Biosciences Limited Incorporates Wholly Owned Subsidiary Company in Dubai | CI |
Sales 2022 | 7.79B 93.51M | Sales 2023 | 6.91B 82.89M | Capitalization | 18.09B 217M |
---|---|---|---|---|---|
Net income 2022 | 958M 11.5M | Net income 2023 | 797M 9.57M | EV / Sales 2022 | 3.16 x |
Net Debt 2022 | 528M 6.33M | Net Debt 2023 | 3.06B 36.68M | EV / Sales 2023 | 3.06 x |
P/E ratio 2022 |
25.2
x | P/E ratio 2023 |
22.7
x | Employees | 1,628 |
Yield 2022 |
0.04% | Yield 2023 |
0.05% | Free-Float | 22.34% |
Latest transcript on Gufic Biosciences Limited
1 day | -0.12% | ||
1 week | +7.84% | ||
Current month | +12.98% | ||
1 month | +9.86% | ||
3 months | -7.82% | ||
6 months | +28.68% | ||
Current year | +1.39% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 41 | 04-06-24 | |
Chief Executive Officer | - | 99-08-30 | |
Director of Finance/CFO | - | 18-10-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 99-08-30 | |
Chief Executive Officer | 41 | 04-06-24 | |
Director/Board Member | 64 | 86-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 319.9 | -0.12% | 1 418 |
24-04-25 | 320.3 | +1.60% | 10,354 |
24-04-24 | 315.2 | -1.76% | 15,137 |
24-04-23 | 320.9 | +7.72% | 9,721 |
24-04-22 | 297.9 | +0.42% | 6,113 |
Delayed Quote Bombay S.E., April 26, 2024 at 01:03 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+1.39% | 386M | |
+24.17% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.45% | 233B | |
+6.04% | 201B | |
-10.51% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |
- Stock Market
- Equities
- GUFICBIO Stock